Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.

about

Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide.

Item

http://www.wikidata.org/entity/Q48748992

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@en

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@nl

type

Item

label

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@en

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@nl

prefLabel

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@en

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@nl

P1476

Improved Neuroprotection Provi ...... ved Soluble Amyloid-β Peptide.

@en

P2093

Ahmad Allouche

http://www.w3.org/2001/XMLSchema#string

Catherine Corbier

http://www.w3.org/2001/XMLSchema#string

Catherine Malaplate-Armand

http://www.w3.org/2001/XMLSchema#string

Frances T Yen

http://www.w3.org/2001/XMLSchema#string

Julie Colin

http://www.w3.org/2001/XMLSchema#string

Lynn Pauron-Gregory

http://www.w3.org/2001/XMLSchema#string

Marie-Claire Lanhers

http://www.w3.org/2001/XMLSchema#string

Thierry Oster

http://www.w3.org/2001/XMLSchema#string

Thomas Claudepierre

http://www.w3.org/2001/XMLSchema#string

P2860

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Alzheimer's disease: the amyloid cascade hypothesis

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

P304

975-987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-151110

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabien Chauveau

P577

2016-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27163806

http://www.w3.org/2001/XMLSchema#string